Authors:
KOTLOFF KL
WASSERMAN SS
RUSS K
SHAPIRO S
DANIEL R
BROWN W
FROST A
TABARA SO
SHAH K
Citation: Kl. Kotloff et al., DETECTION OF GENITAL HUMAN-PAPILLOMAVIRUS AND ASSOCIATED CYTOLOGICAL ABNORMALITIES AMONG COLLEGE-WOMEN, Sexually transmitted diseases, 25(5), 1998, pp. 243-250
Authors:
PERRY RT
PLOWE CV
KOUMARE B
BOUGOUDOGO F
KOTLOFF KL
LOSONSKY GA
WASSERMAN SS
LEVINE MM
Citation: Rt. Perry et al., A SINGLE-DOSE OF LIVE ORAL CHOLERA VACCINE CVD 103-HGR IS SAFE AND IMMUNOGENIC IN HIV-INFECTED AND HIV-NONINFECTED ADULTS IN MALI, Bulletin of the World Health Organization, 76(1), 1998, pp. 63-71
Authors:
VISCIDI RP
KOTLOFF KL
CLAYMAN B
RUSS K
SHAPIRO S
SHAH KV
Citation: Rp. Viscidi et al., PREVALENCE OF ANTIBODIES TO HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 VIRUS-LIKE PARTICLES IN RELATION TO CERVICAL HPV INFECTION AMONG COLLEGE-WOMEN, Clinical and diagnostic laboratory immunology, 4(2), 1997, pp. 122-126
Authors:
TACKET CO
KOTLOFF KL
LOSONSKY G
NATARO JP
MICHALSKI J
KAPER JB
EDELMAN R
LEVINE MM
Citation: Co. Tacket et al., VOLUNTEER STUDIES INVESTIGATING THE SAFETY AND EFFICACY OF LIVE ORAL EL-TOR VIBRIO-CHOLERAE-01 VACCINE STRAIN CVD-111, The American journal of tropical medicine and hygiene, 56(5), 1997, pp. 533-537
Authors:
IYENGAR S
SHAH KV
KOTLOFF KL
GHIM SJ
VISCIDI RP
Citation: S. Iyengar et al., SELF-ASSEMBLY OF IN VITRO-TRANSLATED HUMAN PAPILLOMAVIRUS TYPE-16 L1 CAPSID PROTEIN INTO VIRUS-LIKE PARTICLES AND ANTIGENIC REACTIVITY OF THE PROTEIN, Clinical and diagnostic laboratory immunology, 3(6), 1996, pp. 733-739
Authors:
BASHAM LE
PAVLIAK V
LI XR
HAWWARI A
KOTLOFF KL
EDELMAN R
FATTOM A
Citation: Le. Basham et al., A SIMPLE, QUANTITATIVE, REPRODUCIBLE AVIDIN-BIOTIN ELISA FOR THE EVALUATION OF GROUP-B STREPTOCOCCUS TYPE-SPECIFIC ANTIBODIES IN HUMANS, Vaccine, 14(5), 1996, pp. 439-445
Authors:
KOTLOFF KL
FATTOM A
BASHAM L
HAWWARI A
HARKONEN S
EDELMAN R
Citation: Kl. Kotloff et al., SAFETY AND IMMUNOGENICITY OF A TETRAVALENT GROUP-B STREPTOCOCCAL POLYSACCHARIDE VACCINE IN HEALTHY-ADULTS, Vaccine, 14(5), 1996, pp. 446-450
Citation: Kl. Kotloff, HELICOBACTER-PYLORI AND GASTRODUODENAL DISORDERS - NEW APPROACHES FORPREVENTION, DIAGNOSIS AND TREATMENT, Vaccine, 14(12), 1996, pp. 1174-1175
Authors:
KOTLOFF KL
NORIEGA F
LOSONSKY GA
SZTEIN MB
WASSERMAN SS
NATARO JP
LEVINE MM
Citation: Kl. Kotloff et al., SAFETY, IMMUNOGENICITY, AND TRANSMISSIBILITY IN HUMANS OF CVD-1203, ALIVE ORAL SHIGELLA-FLEXNERI-2A VACCINE CANDIDATE ATTENUATED BY DELETIONS IN AROA AND VIRG, Infection and immunity, 64(11), 1996, pp. 4542-4548
Authors:
KOTLOFF KL
LOSONSKY GA
NATARO JP
WASSERMAN SS
HALE TL
TAYLOR DN
NEWLAND JW
SADOFF JC
FORMAL SB
LEVINE MM
Citation: Kl. Kotloff et al., EVALUATION OF THE SAFETY, IMMUNOGENICITY, AND EFFICACY IN HEALTHY-ADULTS OF 4 DOSES OF LIVE ORAL HYBRID ESCHERICHIA-COLI SHIGELLA-FLEXNERI 2A VACCINE STRAIN ECSF2A-2, Vaccine, 13(5), 1995, pp. 495-502
Authors:
KOTLOFF KL
NATARO JP
LOSONSKY GA
WASSERMAN SS
HALE TL
TAYLOR DN
SADOFF JC
LEVINE MM
Citation: Kl. Kotloff et al., A MODIFIED SHIGELLA VOLUNTEER CHALLENGE MODEL IN WHICH THE INOCULUM IS ADMINISTERED WITH BICARBONATE BUFFER - CLINICAL-EXPERIENCE AND IMPLICATIONS FOR SHIGELLA INFECTIVITY, Vaccine, 13(16), 1995, pp. 1488-1494
Authors:
KOTLOFF KL
JOHNSON JP
NAIR P
HICKMAN D
LIPPINCOTT P
WILSON PD
CLEMENS JD
Citation: Kl. Kotloff et al., DIARRHEAL MORBIDITY DURING THE 1ST 2 YEARS OF LIFE AMONG HIV-INFECTEDINFANTS, JAMA, the journal of the American Medical Association, 271(6), 1994, pp. 448-452
Authors:
WASSERMAN SS
KOTLOFF KL
LOSONSKY GA
LEVINE MM
Citation: Ss. Wasserman et al., IMMUNOLOGICAL RESPONSE TO ORAL CHOLERA VACCINATION IN A CROSSOVER STUDY - A NOVEL PLACEBO-EFFECT, American journal of epidemiology, 138(11), 1993, pp. 988-993